IBDEI0UW ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13756,1,4,0)
 ;;=4^H35.3110
 ;;^UTILITY(U,$J,358.3,13756,2)
 ;;=^5138500
 ;;^UTILITY(U,$J,358.3,13757,0)
 ;;=H35.3111^^83^816^39
 ;;^UTILITY(U,$J,358.3,13757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13757,1,3,0)
 ;;=3^Nonexudative Age-Related Mclr Degn,Right Eye,Early Dry Stage
 ;;^UTILITY(U,$J,358.3,13757,1,4,0)
 ;;=4^H35.3111
 ;;^UTILITY(U,$J,358.3,13757,2)
 ;;=^5138501
 ;;^UTILITY(U,$J,358.3,13758,0)
 ;;=H35.3112^^83^816^40
 ;;^UTILITY(U,$J,358.3,13758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13758,1,3,0)
 ;;=3^Nonexudative Age-Related Mclr Degn,Right Eye,Intermed Dry Stage
 ;;^UTILITY(U,$J,358.3,13758,1,4,0)
 ;;=4^H35.3112
 ;;^UTILITY(U,$J,358.3,13758,2)
 ;;=^5138502
 ;;^UTILITY(U,$J,358.3,13759,0)
 ;;=H35.3120^^83^816^35
 ;;^UTILITY(U,$J,358.3,13759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13759,1,3,0)
 ;;=3^Nonexudative Age-Related Mclr Degn,Left Eye,Stage Unspec
 ;;^UTILITY(U,$J,358.3,13759,1,4,0)
 ;;=4^H35.3120
 ;;^UTILITY(U,$J,358.3,13759,2)
 ;;=^5138505
 ;;^UTILITY(U,$J,358.3,13760,0)
 ;;=H35.3121^^83^816^36
 ;;^UTILITY(U,$J,358.3,13760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13760,1,3,0)
 ;;=3^Nonexudative Age-Related Mclr Degn,Left Eye,Dry Stage
 ;;^UTILITY(U,$J,358.3,13760,1,4,0)
 ;;=4^H35.3121
 ;;^UTILITY(U,$J,358.3,13760,2)
 ;;=^5138506
 ;;^UTILITY(U,$J,358.3,13761,0)
 ;;=H35.3122^^83^816^37
 ;;^UTILITY(U,$J,358.3,13761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13761,1,3,0)
 ;;=3^Nonexudative Age-Related Mclr Degn,Left Eye,Intermed Dry Stage
 ;;^UTILITY(U,$J,358.3,13761,1,4,0)
 ;;=4^H35.3122
 ;;^UTILITY(U,$J,358.3,13761,2)
 ;;=^5138507
 ;;^UTILITY(U,$J,358.3,13762,0)
 ;;=H35.3130^^83^816^32
 ;;^UTILITY(U,$J,358.3,13762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13762,1,3,0)
 ;;=3^Nonexudative Age-Related Mclr Degn,Bilateral,Stage Unspec
 ;;^UTILITY(U,$J,358.3,13762,1,4,0)
 ;;=4^H35.3130
 ;;^UTILITY(U,$J,358.3,13762,2)
 ;;=^5138510
 ;;^UTILITY(U,$J,358.3,13763,0)
 ;;=H35.3131^^83^816^33
 ;;^UTILITY(U,$J,358.3,13763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13763,1,3,0)
 ;;=3^Nonexudative Age-Related Mclr Degn,Bilateral,Early Dry Stage
 ;;^UTILITY(U,$J,358.3,13763,1,4,0)
 ;;=4^H35.3131
 ;;^UTILITY(U,$J,358.3,13763,2)
 ;;=^5138511
 ;;^UTILITY(U,$J,358.3,13764,0)
 ;;=H35.3132^^83^816^34
 ;;^UTILITY(U,$J,358.3,13764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13764,1,3,0)
 ;;=3^Nonexudative Age-Related Mclr Degn,Bilateral,Intermed Dry Stage
 ;;^UTILITY(U,$J,358.3,13764,1,4,0)
 ;;=4^H35.3132
 ;;^UTILITY(U,$J,358.3,13764,2)
 ;;=^5138512
 ;;^UTILITY(U,$J,358.3,13765,0)
 ;;=H35.3210^^83^816^25
 ;;^UTILITY(U,$J,358.3,13765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13765,1,3,0)
 ;;=3^Exudative Age-Related Mclr Degn,Right Eye,Stage Unspec
 ;;^UTILITY(U,$J,358.3,13765,1,4,0)
 ;;=4^H35.3210
 ;;^UTILITY(U,$J,358.3,13765,2)
 ;;=^5138520
 ;;^UTILITY(U,$J,358.3,13766,0)
 ;;=H35.3211^^83^816^26
 ;;^UTILITY(U,$J,358.3,13766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13766,1,3,0)
 ;;=3^Exudative Age-Related Mclr Degn,Right Eye,w/ Actv Chrdl Neovas
 ;;^UTILITY(U,$J,358.3,13766,1,4,0)
 ;;=4^H35.3211
 ;;^UTILITY(U,$J,358.3,13766,2)
 ;;=^5138521
 ;;^UTILITY(U,$J,358.3,13767,0)
 ;;=H35.3212^^83^816^27
 ;;^UTILITY(U,$J,358.3,13767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13767,1,3,0)
 ;;=3^Exudative Age-Related Mclr Degn,Right Eye,w/ Inact Chrdl Neovas
 ;;^UTILITY(U,$J,358.3,13767,1,4,0)
 ;;=4^H35.3212
